The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / UnitedHealth Boosts Earnings Forecast, Set to Pass Price Discounts to Patients

UnitedHealth Boosts Earnings Forecast, Set to Pass Price Discounts to Patients

July 22, 2019 • By Tamara Mathias and Caroline Humer

  • Tweet
  • Email
Print-Friendly Version / Save PDF

July 18 (Reuters)—UnitedHealth Group Inc. will stick with its decision to pass on drug maker discounts to patients to help them beat rising medicine prices despite the U.S. government having withdrawn a similar proposed policy in its health programs, its top executive said on Thursday.

You Might Also Like
  • UnitedHealth Sees More Growth in 2017 When It Exits Obamacare
  • UnitedHealth Sees Further Losses for Obamacare Insurance
  • UnitedHealth Sued by U.S. Over Medicare Charges

“You can expect us not to change our stance on rebates,” Chief Executive Officer David Wichmann said on a conference call with analysts to discuss the earnings.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

UnitedHealth shares were down $5.65, or 2%, at $260.94 in morning trading, after earlier rising about 1% in premarket trading on news the company beat estimates for quarterly profit and boosted its forecast for 2019 earnings.

The share decline came after the conference call, in which the company said 2019 revenue would not hit the company’s original target.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We think UnitedHealth is underperforming the peers today likely because on the call, they guided 2019 revenues to now be ‘at or slightly below’ the prior revenue guidance range of $243-245 billion,” Scott Fidel an analyst at Stephens said.

Two analysts and one investor said the decision to stick with its point-of-sale rebates did not seem to be linked to the share price fall.

UnitedHealth said in March its pharmacy-benefit management unit OptumRx would only sell new health plans that give the after-market discounts it negotiates with drugmakers directly to patients. About 9 million of its customers are in such plans this year.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The company is the first U.S. health insurer to report quarterly results after the Trump administration last week shelved its proposal to pass billions of dollars in rebates to Medicare patients.

Pharmacy benefits managers receive after-market discounts from drug companies and allow their clients, such as large employers, to incorporate them into overall premium pricing or share them with patients.

Wichmann said the government’s decision showed that the Trump administration values pharmacy benefit managers as a “counterbalance” to drug prices.

UnitedHealth and other insurers still face other potential health policy changes and pressure as rising healthcare costs take the center stage in debates ahead of the 2020 U.S. presidential elections.

Some Democratic candidates have proposed a complete ban on private health insurance in favor of a government-run Medicare-for-all plan.

Revenue Outlook Lowered

UnitedHealth Chief Financial Officer John Rex said he expects 2019 revenue to be “at or just slightly below” its previously given range of $243 billion to $245 billion in 2019.

UnitedHealth raised its full-year adjusted earnings forecast to between $14.70 and $14.90 per share, from an earlier forecast of between $14.50 and $14.75 per share.

Pages: 1 2 | Single Page

Filed Under: Pharma Co. News Tagged With: David Wichmann, drug maker discounts, drug pricing, drug rebates, healthcare costs, UnitedHealth Group Inc.

You Might Also Like:
  • UnitedHealth Sees More Growth in 2017 When It Exits Obamacare
  • UnitedHealth Sees Further Losses for Obamacare Insurance
  • UnitedHealth Sued by U.S. Over Medicare Charges
  • Anthem May Exit More Individual Markets over Obamacare Funding

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)